117 related articles for article (PubMed ID: 19505970)
1. Implantation of fiducial markers for image guidance in prostate radiotherapy: patient-reported toxicity.
Igdem S; Akpinar H; Alço G; Agaçayak F; Turkan S; Okkan S
Br J Radiol; 2009 Nov; 82(983):941-5. PubMed ID: 19505970
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy.
Gill S; Li J; Thomas J; Bressel M; Thursky K; Styles C; Tai KH; Duchesne GM; Foroudi F
Br J Radiol; 2012 Jul; 85(1015):1011-7. PubMed ID: 22253345
[TBL] [Abstract][Full Text] [Related]
3. [Use of gold radionuclide markers implanted into the prostate for image-guided radiotherapy in prostate cancer: side effects caused by the marker implantation].
Kliton J; Ágoston P; Szabó Z; Major T; Polgár C
Magy Onkol; 2014 Sep; 58(3):182-7. PubMed ID: 25260082
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-guided transrectal implantation of fiducial markers for image-guided radiotherapy of prostate cancer without local anesthesia: Patient-reported gastrointestinal-genitourinary system complications and pain.
Sen CA
J Cancer Res Ther; 2021; 17(2):353-357. PubMed ID: 34121677
[TBL] [Abstract][Full Text] [Related]
5. Transperineal gold marker implantation for image-guided external beam radiotherapy of prostate cancer : A single institution, prospective study.
Jorgo K; Ágoston P; Major T; Takácsi-Nagy Z; Polgár C
Strahlenther Onkol; 2017 Jun; 193(6):452-458. PubMed ID: 28154882
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors.
Langenhuijsen JF; van Lin EN; Kiemeney LA; van der Vight LP; McColl GM; Visser AG; Witjes JA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):671-6. PubMed ID: 17512133
[TBL] [Abstract][Full Text] [Related]
7. Postprostatectomy ultrasound-guided transrectal implantation of gold markers for external beam radiotherapy. Technique and complications rate.
Langenhuijsen JF; Donker R; McColl GM; Kiemeney LA; Witjes JA; van Lin EN
Strahlenther Onkol; 2013 Jun; 189(6):476-81. PubMed ID: 23604186
[TBL] [Abstract][Full Text] [Related]
8. Fiducial markers implantation for prostate image-guided radiotherapy: a report on the transperineal approach.
De Cicco L; Bracelli S
Radiol Med; 2019 Feb; 124(2):132-135. PubMed ID: 30361924
[TBL] [Abstract][Full Text] [Related]
9. Fiducial marker implantation in prostate radiation therapy: complication rates and technique.
Fawaz ZS; Yassa M; Nguyen DH; Vavassis P
Cancer Radiother; 2014 Dec; 18(8):736-9. PubMed ID: 25451675
[TBL] [Abstract][Full Text] [Related]
10. Technique for implantation of fiducial markers in the prostate.
Shinohara K; Roach M
Urology; 2008 Feb; 71(2):196-200. PubMed ID: 18308082
[TBL] [Abstract][Full Text] [Related]
11. [Intraprostatic fiducials in stereotactic radiotherapy for prostate cancer].
Cordoba A; Pasquier D; Nickers P; Lacornerie T; Lartigau É
Cancer Radiother; 2016 Dec; 20(8):815-819. PubMed ID: 27793529
[TBL] [Abstract][Full Text] [Related]
12. Prostatic fiducial markers implantation by transrectal ultrasound for adaptive image guided radiotherapy in localized cancer: 7-years experience.
Lacetera V; Cardinali M; Mantello G; Fenu F; Sbrollini G; Tombolini F; Conti A; Maggi S; Muzzonigro G; Galosi AB
Arch Ital Urol Androl; 2014 Dec; 86(4):349-52. PubMed ID: 25641469
[TBL] [Abstract][Full Text] [Related]
13. Transperineal implantation of gold fiducial markers (gold seeds) for prostate image-guided radiation therapy: a feasible technique associated with a low risk of complications.
Saad A; Goldstein J; Lawrence YR; Weiss I; Saad R; Spieler B; Symon Z
J Med Radiat Sci; 2015 Dec; 62(4):261-6. PubMed ID: 27512572
[TBL] [Abstract][Full Text] [Related]
14. Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?
Loh J; Baker K; Sridharan S; Greer P; Wratten C; Capp A; Gallagher S; Martin J
Radiat Oncol; 2015 Feb; 10():38. PubMed ID: 25890179
[TBL] [Abstract][Full Text] [Related]
15. Long-term experience with transrectal and transperineal implantations of fiducial gold markers in the prostate for position verification in external beam radiotherapy; feasibility, toxicity and quality of life.
Moman MR; van der Heide UA; Kotte AN; van Moorselaar RJ; Bol GH; Franken SP; van Vulpen M
Radiother Oncol; 2010 Jul; 96(1):38-42. PubMed ID: 20334942
[TBL] [Abstract][Full Text] [Related]
16. Safety and detailed patterns of morbidity of transrectal ultrasound guided needle biopsy of prostate in a urologist-led unit.
Lee G; Attar K; Laniado M; Karim O
Int Urol Nephrol; 2006; 38(2):281-5. PubMed ID: 16868698
[TBL] [Abstract][Full Text] [Related]
17. Assessment of prostatic fiducial marker introduction: patient morbidity, staff satisfaction and improved treatment field placement.
Brown S; Lehman M; Ferrari-Anderson J; Glyde A; Burmeister E; Nicol D
J Med Imaging Radiat Oncol; 2011 Aug; 55(4):417-24. PubMed ID: 21843178
[TBL] [Abstract][Full Text] [Related]
18. Single-center experience in prostate fiducial marker placement: technique and midterm follow-up.
Kably I; Bordegaray M; Shah K; Salsamendi J; Narayanan G
J Vasc Interv Radiol; 2014 Jul; 25(7):1125-1132.e1. PubMed ID: 24788207
[TBL] [Abstract][Full Text] [Related]
19. Improving positioning in high-dose radiotherapy for prostate cancer: safety and visibility of frequently used gold fiducial markers.
Fonteyne V; Ost P; Villeirs G; Oosterlinck W; Impens A; De Gersem W; De Wagter C; De Meerleer G
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):46-52. PubMed ID: 22014956
[TBL] [Abstract][Full Text] [Related]
20. Patient tolerance of transrectal ultrasound-guided biopsy of the prostate.
Irani J; Fournier F; Bon D; Gremmo E; Doré B; Aubert J
Br J Urol; 1997 Apr; 79(4):608-10. PubMed ID: 9126093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
